Keros Therapeutics, Inc. is a company that provides Fibrodysplasia ossificans progressiva, Pharmacy and Therapeutics, Anemia and more. Keros Therapeutics, Inc. is headquartered in United States Massachusetts. Keros Therapeutics, Inc. was founded in 2015. Keros Therapeutics, Inc. has a total of 164 patents and 5 literature
Keros is a clinical-stage biopharmaceutical company focused on the discovery, development and commercialization of novel treatments for patients suffering...
What is Keros Therapeutics, Inc.'s official website?